Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
157 hedge funds and large institutions have $1.51B invested in Spectrum Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 70 increasing their positions, 39 reducing their positions, and 32 closing their positions.
79% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 39
48% more capital invested
Capital invested by funds: $1.02B → $1.51B (+$487M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 158 → 157 (-1)
3% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 32
66% less call options, than puts
Call options by funds: $8.27M | Put options by funds: $24.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$72.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$24.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$24M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$19.5M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$18.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$15.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.92M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MC
176
Miles Capital
West Des Moines,
Iowa
| – | -$225K | -16,005 | Closed |
|
|
BCM
177
Bayesian Capital Management
Brooklyn,
New York
| – | -$223K | -15,854 | Closed |
|
|
EMG
178
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$221K | -15,700 | Closed |
|
|
CCIA
179
Campbell & Co Investment Adviser
Baltimore,
Maryland
| – | -$192K | -13,639 | Closed |
|
180
Los Angeles Capital Management
Los Angeles,
California
| – | -$177K | -12,560 | Closed |
|
181
Jane Street
New York
| – | -$152K | -10,774 | Closed |
|
|
AP
182
AHL Partners
London,
United Kingdom
| – | -$141K | -10,036 | Closed |
|
|
QT
183
Quantbot Technologies
New York
| – | -$96K | -6,856 | Closed |
|
184
Acadian Asset Management
Boston,
Massachusetts
| – | -$36K | -2,525 | Closed |
|
185
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$17K | -1,183 | Closed |
|
|
AIM
186
Advantage Investment Management
Cedar Rapids,
Iowa
| – | -$12K | -877 | Closed |
|
|
KF
187
Krilogy Financial
St. Louis,
Missouri
| – | -$7K | -500 | Closed |
|
|
LFA
188
Legacy Financial Advisors
Covington,
Kentucky
| – | +$435 | +24 | New |
|
SPPI Hedge Fund Activity: Q4 2017 in Review
157 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2017, worth a combined $1.51B — up 48% from $1.02B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of SPPI and 31 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 70 added.
The largest buyer was BlackRock, adding an estimated $72.7M. The largest seller was Consonance Capital Management, cutting an estimated $24M.
- 157 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2017, down from 158 in Q3 2017.
- Funds reported $1.51B of Spectrum Pharmaceuticals Inc stock for Q4 2017, up 48% quarter-over-quarter.
- 31 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2017 and 32 closed out, a net change of -1 holder.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2017 was BlackRock, an estimated $72.7M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2017 was Consonance Capital Management, an estimated $24M sold.
Based on aggregated 13F filings for Q4 2017.